These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29876622)

  • 1. Inhibition of phosphodiesterase 2 by Bay 60-7550 decreases ethanol intake and preference in mice.
    Shi J; Liu H; Pan J; Chen J; Zhang N; Liu K; Fei N; O'Donnell JM; Zhang HT; Xu Y
    Psychopharmacology (Berl); 2018 Aug; 235(8):2377-2385. PubMed ID: 29876622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Phosphodiesterase 2 Ameliorates Post-Traumatic Stress-Induced Alcohol Intake Disorder by Regulating cAMP/cGMP Signaling.
    Pan X; Chen L; Shan C; Cai L; Wang Y; Chen Y; Gu M; Liu K; Li P; Pan J
    Int J Neuropsychopharmacol; 2022 Nov; 25(11):936-945. PubMed ID: 36124735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway.
    Xu Y; Pan J; Chen L; Zhang C; Sun J; Li J; Nguyen L; Nair N; Zhang H; O'Donnell JM
    Int J Neuropsychopharmacol; 2013 May; 16(4):835-47. PubMed ID: 22850435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phosphodiesterase 2 reverses gp91phox oxidase-mediated depression- and anxiety-like behavior.
    Huang X; Xiaokaiti Y; Yang J; Pan J; Li Z; Luria V; Li Y; Song G; Zhu X; Zhang HT; O'Donnell JM; Xu Y
    Neuropharmacology; 2018 Dec; 143():176-185. PubMed ID: 30268520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice.
    Lueptow LM; Zhan CG; O'Donnell JM
    Psychopharmacology (Berl); 2016 Feb; 233(3):447-56. PubMed ID: 26525565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase-2 inhibitor reverses post-traumatic stress induced fear memory deficits and behavioral changes via cAMP/cGMP pathway.
    Chen L; Liu K; Wang Y; Liu N; Yao M; Hu J; Wang G; Sun Y; Pan J
    Eur J Pharmacol; 2021 Jan; 891():173768. PubMed ID: 33271150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of phosphodiesterase-4 decreases ethanol intake in mice.
    Hu W; Lu T; Chen A; Huang Y; Hansen R; Chandler LJ; Zhang HT
    Psychopharmacology (Berl); 2011 Nov; 218(2):331-9. PubMed ID: 21509503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress.
    Xu Y; Pan J; Sun J; Ding L; Ruan L; Reed M; Yu X; Klabnik J; Lin D; Li J; Chen L; Zhang C; Zhang H; O'Donnell JM
    Neurobiol Aging; 2015 Feb; 36(2):955-70. PubMed ID: 25442113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.
    Bubb KJ; Trinder SL; Baliga RS; Patel J; Clapp LH; MacAllister RJ; Hobbs AJ
    Circulation; 2014 Aug; 130(6):496-507. PubMed ID: 24899690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphodiesterase type 2 inhibitor BAY 60-7550 reverses functional impairments induced by brain ischemia by decreasing hippocampal neurodegeneration and enhancing hippocampal neuronal plasticity.
    Soares LM; Meyer E; Milani H; Steinbusch HW; Prickaerts J; de Oliveira RM
    Eur J Neurosci; 2017 Feb; 45(4):510-520. PubMed ID: 27813297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice.
    Liu X; Hao PD; Yang MF; Sun JY; Mao LL; Fan CD; Zhang ZY; Li DW; Yang XY; Sun BL; Zhang HT
    Psychopharmacology (Berl); 2017 Aug; 234(16):2409-2419. PubMed ID: 28477089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition.
    Abusnina A; Keravis T; Zhou Q; Justiniano H; Lobstein A; Lugnier C
    Thromb Haemost; 2015 Feb; 113(2):319-28. PubMed ID: 25230992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of phosphodiesterase 2 inhibitor on depression- and anxiety-like behaviors: involvement of antioxidant and anti-apoptotic mechanisms.
    Ding L; Zhang C; Masood A; Li J; Sun J; Nadeem A; Zhang HT; O' Donnell JM; Xu Y
    Behav Brain Res; 2014 Jul; 268():150-158. PubMed ID: 24694839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PDE2 reverses beta amyloid induced memory impairment through regulation of PKA/PKG-dependent neuro-inflammatory and apoptotic pathways.
    Wang L; Xiaokaiti Y; Wang G; Xu X; Chen L; Huang X; Liu L; Pan J; Hu S; Chen Z; Xu Y
    Sci Rep; 2017 Sep; 7(1):12044. PubMed ID: 28935920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion.
    van Donkelaar EL; Rutten K; Blokland A; Akkerman S; Steinbusch HW; Prickaerts J
    Eur J Pharmacol; 2008 Dec; 600(1-3):98-104. PubMed ID: 18957291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bay 60-7550, a PDE2 inhibitor, exerts positive inotropic effect of rat heart by increasing PKA-mediated phosphorylation of phospholamban.
    Wang YW; Gao QW; Xiao YJ; Zhu XJ; Gao L; Zhang WH; Wang RR; Chen KS; Liu FM; Huang HL; Chen L
    Eur J Pharmacol; 2021 Jun; 901():174077. PubMed ID: 33798601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
    Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase 2 inhibitor Hcyb1 reverses corticosterone-induced neurotoxicity and depression-like behavior.
    Zhu MJ; Shi J; Chen Y; Huang G; Zhu XW; Zhang S; Huang XF; Song GQ; Zhang HT; Ke HM; O'Donnell JM; Wang LQ; Xu Y
    Psychopharmacology (Berl); 2020 Nov; 237(11):3215-3224. PubMed ID: 32926224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
    Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
    J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase 2 and Its Isoform A as Therapeutic Targets in the Central Nervous System Disorders.
    Metkar SK; Yan Y; Lu Y; Lu J; Zhu X; Du F; Xu Y
    CNS Neurol Disord Drug Targets; 2024; 23(8):941-955. PubMed ID: 37855295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.